Our unwavering commitment to the highest pharmaceutical quality standards and full regulatory compliance with FDA Ghana ensures that every product we deliver is safe, effective, and trustworthy.
At Health Foresight Pharma Ltd., quality is not an afterthought — it is the cornerstone of every decision we make. We believe that patients across Ghana deserve access to medicines that are safe, effective, and manufactured to the highest international standards. This belief drives our rigorous quality management approach at every stage of our supply chain, from supplier qualification to end-point delivery.
We source exclusively from pharmaceutical manufacturers certified under WHO Good Manufacturing Practice (WHO-GMP) guidelines and other internationally recognised standards including EU-GMP and US-FDA compliance. Before any product enters our portfolio, it undergoes a comprehensive supplier qualification process that includes documentation review, quality audits, and regulatory status verification. We maintain full traceability for every batch we distribute — enabling rapid response in the event of any quality concern or product recall.
Our internal quality team conducts ongoing monitoring of all products in our portfolio, reviewing batch records, stability data, and post-market feedback. We work in close collaboration with the Ghana Food and Drugs Authority (FDA Ghana) to ensure all products remain compliant with national registration requirements, import permits, and post-approval commitments at all times.
Patient safety remains our highest priority.
Compliance Standards:
All supplier manufacturers hold valid WHO-GMP or equivalent certifications
Rigorous batch testing and quality checks before distribution approval
Validated temperature-controlled storage and transport for sensitive products
Complete batch records, certificates of analysis, and delivery documentation
Ongoing post-market surveillance and product quality review programmes
Full compliance with FDA Ghana regulations and international quality standards
The Ghana Food and Drugs Authority (FDA Ghana) regulates the safety, efficacy, and quality of all pharmaceutical products on the Ghanaian market. Health Foresight Pharma operates in full compliance with all FDA Ghana mandates and requirements.
The Ghana Food and Drugs Authority, established under the Food and Drugs Authority Act 1992 (PNDC Law 305B) and the Food and Drugs Act 1996 (Act 523), is the primary regulatory body responsible for ensuring that all medicines, food, cosmetics, and medical devices marketed in Ghana are safe, efficacious, and of the required quality. Health Foresight Pharma Ltd. maintains a proactive regulatory posture — ensuring that every product in our portfolio holds valid registration, current import permits, and meets all applicable FDA Ghana requirements.
Our Regulatory Affairs team maintains up-to-date knowledge of all FDA Ghana regulatory changes, submitting applications, renewals, and compliance documentation in a timely manner. We conduct annual internal regulatory audits to verify the status of all product licences and import permits within our portfolio.
All pharmaceutical products marketed in Ghana must be registered with the FDA Ghana. We manage the complete registration process for our portfolio — including dossier preparation, submission, follow-up, and certificate management. We ensure all registrations remain current through timely renewal applications before expiry.
Pharmaceutical importation into Ghana requires valid import permits issued by the FDA Ghana for each consignment. Our team manages the full permit application process, ensuring that all required documentation — including certificates of analysis, certificates of origin, and manufacturer certifications — are submitted correctly and on time.
Beyond initial registration, pharmaceutical marketers and distributors in Ghana are required to hold current product marketing licences. We maintain all necessary distributor licences and ensure our operations align fully with FDA Ghana licensing conditions — including storage standards, documentation requirements, and reporting obligations.
Our regulatory team handles all types of submissions to the FDA Ghana — from new product applications and variation notifications to post-approval commitments and adverse event reports. We ensure all submissions are complete, accurate, and submitted within the required timeframes, maintaining our strong compliance record.
Good Distribution Practices are a quality warranty system for the proper distribution and handling of pharmaceutical products — ensuring product integrity is maintained throughout the entire supply chain.
Health Foresight Pharma Ltd. adheres strictly to Good Distribution Practices (GDP) as defined by the World Health Organization and the Ghana Food and Drugs Authority. GDP compliance ensures that the quality and integrity of pharmaceutical products are maintained throughout the distribution chain — from our warehouse to the point of dispensing. Our GDP framework covers every aspect of pharmaceutical handling: receiving, storage, picking, packing, dispatch, and transport.
Our warehouse facilities are designed and maintained in full compliance with GDP standards, with dedicated zones for ambient, refrigerated, and controlled storage. All staff handling pharmaceutical products receive comprehensive GDP training and are assessed regularly on their compliance competence. Our GDP system includes robust procedures for managing product recalls, handling customer complaints, and responding to quality incidents swiftly and transparently.
Download GDP PolicyGhana FDA requires all pharmaceutical companies operating in Ghana to maintain robust pharmacovigilance systems for the ongoing monitoring and reporting of adverse drug reactions and safety signals.
Health Foresight Pharma Ltd. maintains a fully operational pharmacovigilance (PV) system in compliance with the Ghana Food and Drugs Authority's PV requirements. Our PV programme is designed to detect, evaluate, understand, and prevent adverse effects and other medicine-related problems, ensuring the continued safety of patients who use our products.
We have established structured processes for collecting adverse drug reaction (ADR) reports from healthcare professionals, patients, and our own field staff. All reports are assessed, coded, and submitted to the FDA Ghana within the required timeframes. Our PV team also prepares Periodic Safety Update Reports (PSURs) and Risk Management Plans (RMPs) as required by FDA Ghana for specific product categories.
We operate a structured adverse drug reaction collection and reporting system, enabling healthcare professionals and patients to report suspected ADRs through multiple channels. All reports are acknowledged, assessed for causality, and submitted to the FDA Ghana within mandatory reporting timelines — 7 days for serious unexpected reactions and 15 days for all other serious reactions.
Report an ADROur pharmacovigilance team conducts regular signal detection exercises — analysing aggregate ADR data to identify potential new safety concerns, changes in the benefit-risk profile of products, or previously unrecognised drug interactions. Detected signals are evaluated and escalated to manufacturers and the FDA Ghana as appropriate.
We prepare and coordinate Periodic Safety Update Reports (PSURs) for applicable products in our portfolio, summarising the worldwide safety experience, analysis of benefit-risk balance, and any new safety information identified during the reporting period. PSURs are submitted to the FDA Ghana in compliance with prescribed schedules and formats.
Quality assurance does not stop at the point of sale. Our post-market surveillance programme ensures continuous monitoring of product quality throughout the product lifecycle in the Ghanaian market.
Health Foresight Pharma Ltd. maintains an active post-market surveillance programme that monitors the quality, safety, and performance of all pharmaceutical products in our distribution portfolio. This programme includes structured field inspections, regular engagement with healthcare providers to collect product quality feedback, and systematic review of product complaint data.
Our expiry date management system ensures that products approaching their expiry date are identified, segregated, and managed appropriately — preventing dispensing of expired medicines at any point in our supply chain. We conduct quarterly expiry audits across our entire inventory, working proactively with our customers to rotate or replace products before expiry.
In the event of a product recall — whether initiated by the manufacturer, the FDA Ghana, or identified internally — our recall procedures enable us to identify and quarantine all affected batches across our network within 24 hours, with full traceability to the dispensing point.